Reference(s)
Click here to return to the Reference Table

Category: Other Neoplasms
Cancer type: Mesothelioma
Descriptor: Met expression


Reference Number: 211
Tolnay, E. et al. Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma. J Cancer Res Clin Oncol 124, 291-6 (1998).
PubMed link      E-mail link

Reference Number: 212
Klominek, J., Baskin, B., Liu, Z. & Hauzenberger, D. Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor. Int J Cancer 76, 240-9 (1998).
PubMed link      E-mail link

Reference Number: 213
Thirkettle, I., Harvey, P., Hasleton, P. S., Ball, R. Y. & Warn, R. M. Immunoreactivity for cadherins, HGF/SF, met, and erbB-2 in pleural malignant mesotheliomas. Histopathology 36, 522-8 (2000).
PubMed link      E-mail link

Reference Number: 416
Jagadeeswaran R, Ma PC, Seiwert TY, Jagadeeswaran S, Zumba O, Nallasura V, Ahmed S, Filiberti R, Paganuzzi M, Puntoni R, Kratzke RA, Gordon GJ, Sugarbaker DJ, Bueno R, Janamanchi V, Bindokas VP, Kindler HL, Salgia R. Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma. Cancer Res. 66, 352-61 (2006)
PubMed link      E-mail link

Reference Number: 417
Mukohara T, Civiello G, Davis IJ, Taffaro ML, Christensen J, Fisher DE, Johnson BE, Janne PA. Inhibition of the met receptor in mesothelioma. Clin Cancer Res. 11, 8122-30 (2005)
PubMed link      E-mail link

Reference Number: 421
Vogelzang NJ, Porta C, Mutti L. New agents in the management of advanced mesothelioma. Semin Oncol. 32, 336-50 (2005)
PubMed link      E-mail link

Reference Number: 423
Zimmerman RL, Fogt F. Evaluation of the c-Met immunostain to detect malignant cells in body cavity effusions. Oncol Rep. 8, 1347-50 (2001)
PubMed link      E-mail link

Reference Number: 424
Cacciotti P, Libener R, Betta P, Martini F, Porta C, Procopio A, Strizzi L, Penengo L, Tognon M, Mutti L, Gaudino G. SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma. Proc Natl Acad Sci U S A. 98, 12032-7 (2001)
PubMed link      E-mail link

Reference Number: 426
Thirkettle I, Harvey P, Hasleton PS, Ball RY, Warn RM. Immunoreactivity for cadherins, HGF/SF, met, and erbB-2 in pleural malignant mesotheliomas. Histopathology.  36, 522-8 (2000)
PubMed link      E-mail link

Reference Number: 428
Klominek J, Baskin B, Liu Z, Hauzenberger Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor.D. Int J Cancer. 76, 240-9 (1998)
PubMed link      E-mail link

Reference Number: 797
Suzuki Y, Sakai K, Ueki J, Xu Q, Nakamura T, Shimada H, Nakamura T, Matsumoto K. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma. Int J Cancer. 127, 1948-57 (2010)
PubMed link      E-mail link

Reference Number: 1129
Brevet M, Shimizu S, Bott MJ, Shukla N, Zhou Q, Olshen AB, Rusch V, Ladanyi M. Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy. J Thorac Oncol. 6, 864-74 (2011)
PubMed link      E-mail link

Reference Number: 1147
Levallet G, Vaisse-Lesteven M, Le Stang N, Ilg AG, Brochard P, Astoul P, Pairon JC, Bergot E, Zalcman G, Galateau-Sallé F. Plasma cell membrane localization of c-MET predicts longer survival in patients with malignant mesothelioma: a series of 157 cases from the MESOPATH Group. J Thorac Oncol. 7, 599-606 (2012)
PubMed link      E-mail link

Reference Number: 1348
Lee YJ1, Lee YJ, Im JH, Won SY, Kim YB, Cho MK, Nam HS, Choi YJ, Lee SH. Synergistic anti-cancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells. Food Chem Toxicol. 52, 61-8 (2013)
PubMed link      E-mail link

Reference Number: 1398
Tanaka N1, Toyooka S, Soh J, Tsukuda K, Shien K, Furukawa M, Muraoka T, Maki Y, Ueno T, Yamamoto H, Asano H, Otsuki T, Miyoshi S. Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells. Oncol Rep. 29, 2169-74 (2013)
PubMed link      E-mail link

Reference Number: 1669
Deng XB, Xiao L, Wu Y, Jin F, Mossman B, Testa JR, Xiao GH. Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy. Int J Cancer. 137, 481-90 (2015)
PubMed link      E-mail link

Reference Number: 1702
Kanteti R, Dhanasingh I, Kawada I, Lennon FE, Arif Q, Bueno R, Hasina R, Husain AN, Vigneswaran W, Seiwert T, Kindler HL, Salgia R. MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma. PLoS One. 9(9):e105919 (2014)
PubMed link      E-mail link